ID
Insider
Ingrid Delaet
Chief Regulatory OfficerIngrid Delaet (Chief Regulatory Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $2.6M of NBIX (14,571 sh across 3 lots, as filed), executed Jul 7.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.7M
shares × price, as filed
Last traded
Jul 10
Filed Jul 13
Median ADV $194.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
NBIX
Neurocrine Biosciences, Inc.
NBIX · 0 buys · 4 sells
4 filings
Recent filings
NBIXSALE
Neurocrine Biosciences, Inc.
View filing →
$791K4,367 sh × $181.02
Exec Jul 10
Filed Jul 13 · 4:27 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $2.6M
14,571 sh across 3 lots
Exec Jul 7
Filed Jul 9 · 6:41 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $354K
2,261 sh × $156.71
Exec May 29
Filed Jun 2 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $147K
1,091 sh × $135.00
Exec Dec 17 2024
Filed Dec 19 2024 · 5:30 PM ET